Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1

INTRODUCTION: We have previously reported that induction of epidermal growth factor receptor and ErbB2 in response to antihormonal agents may provide an early mechanism to allow breast cancer cells to evade the growth-inhibitory action of such therapies and ultimately drive resistant cell growth. Mo...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Hutcheson, Iain R, Goddard, Lindy, Barrow, Denise, McClelland, Richard A, Francies, Hayley E, Knowlden, Janice M, Nicholson, Robert I, Gee, Julia MW
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2011
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3219190/
https://ncbi.nlm.nih.gov/pubmed/21396094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2848
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים